"The life they save may be mine": diffusion of overdose prevention information from a city sponsored programme

Int J Drug Policy. 2009 Mar;20(2):137-42. doi: 10.1016/j.drugpo.2008.02.004. Epub 2008 May 27.

Abstract

Background: Overdose remains the leading cause of death among injection drug users (IDUs) in the United States. Overdose rates are consistently high in Baltimore, MD, USA. The current qualitative study examines diffusion of information and innovation among participants in Staying Alive, an overdose prevention and naloxone distribution programme in Baltimore, MD.

Methods: In-depth interviews were conducted between June 2004 and August, 2005 with 25 participants who had completed the Staying Alive training and had reported using naloxone to revive an overdose victim. Interviews were taped and transcripts were transcribed verbatim.

Results: Participants were 63% male, 63% African American, and the median age was 41 years old. Participants successfully shared information on overdose prevention and management, particularly the use of naloxone, to their peers and family.

Conclusions: The current study demonstrates IDUs' interest in and ability to diffuse overdose prevention information and response skills to the injection drug use community. The study underscores the importance of promoting the diffusion of information and skills within overdose prevention programmes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Baltimore
  • Data Collection
  • Diffusion of Innovation*
  • Drug Overdose / mortality
  • Drug Overdose / therapy
  • Female
  • Humans
  • Information Dissemination / methods*
  • Male
  • Middle Aged
  • Naloxone / administration & dosage
  • Naloxone / supply & distribution
  • Naloxone / therapeutic use
  • Narcotic Antagonists / administration & dosage
  • Narcotic Antagonists / supply & distribution
  • Narcotic Antagonists / therapeutic use
  • Pilot Projects
  • Preventive Health Services / methods
  • Substance Abuse, Intravenous / mortality
  • Substance Abuse, Intravenous / therapy*
  • Young Adult

Substances

  • Narcotic Antagonists
  • Naloxone